442 related articles for article (PubMed ID: 27261582)
21. Effects of Myrtus communis extract treatment in bile duct ligated rats.
Sen A; Ozkan S; Recebova K; Cevik O; Ercan F; Kervancıoglu Demirci E; Bitis L; Sener G
J Surg Res; 2016 Oct; 205(2):359-367. PubMed ID: 27664884
[TBL] [Abstract][Full Text] [Related]
22. Aqueous garlic extract alleviates liver fibrosis and renal dysfunction in bile-duct-ligated rats.
Mahmoud MF; Zakaria S; Fahmy A
Z Naturforsch C J Biosci; 2014; 69(3-4):133-41. PubMed ID: 24873034
[TBL] [Abstract][Full Text] [Related]
23. Silymarin-Loaded Eudragit Nanoparticles: Formulation, Characterization, and Hepatoprotective and Toxicity Evaluation.
El-Nahas AE; Allam AN; Abdelmonsif DA; El-Kamel AH
AAPS PharmSciTech; 2017 Nov; 18(8):3076-3086. PubMed ID: 28516410
[TBL] [Abstract][Full Text] [Related]
24. Sorafenib-loaded PAMAM dendrimer attenuates liver fibrosis and its complications in bile-duct-ligated rats.
Shafie F; Nabavizadeh F; Shafie Ardestani M; Panahi M; Adeli S; Samandari H; Ashabi G
Can J Physiol Pharmacol; 2019 Aug; 97(8):691-698. PubMed ID: 31071278
[TBL] [Abstract][Full Text] [Related]
25. Vitamin D3 abates BDL-induced cholestasis and fibrosis in rats via regulating Hedgehog pathway.
Abdel-Rahman N; Sharawy MH; Megahed N; El-Awady MS
Toxicol Appl Pharmacol; 2019 Oct; 380():114697. PubMed ID: 31394158
[TBL] [Abstract][Full Text] [Related]
26. Assessment of Hepatoprotective Effect of Chokeberry Juice in Rats Treated Chronically with Carbon Tetrachloride.
Piotrowska-Kempisty H; Nowicki M; Jodynis-Liebert J; Kurpik M; Ewertowska M; Adamska T; Oszmiański J; Kujawska M
Molecules; 2020 Mar; 25(6):. PubMed ID: 32168847
[TBL] [Abstract][Full Text] [Related]
27. Antifibrotic effects of Salvia miltiorrhiza on dimethylnitrosamine-intoxicated rats.
Hsu YC; Lin YL; Chiu YT; Shiao MS; Lee CY; Huang YT
J Biomed Sci; 2005; 12(1):185-95. PubMed ID: 15864749
[TBL] [Abstract][Full Text] [Related]
28. Paclitaxel alleviates liver fibrosis induced by bile duct ligation in rats: Role of TGF-β1, IL-10 and c-Myc.
Sharawy MH; Abdel-Rahman N; Megahed N; El-Awady MS
Life Sci; 2018 Oct; 211():245-251. PubMed ID: 30243650
[TBL] [Abstract][Full Text] [Related]
29. Antifibrotic effect of N-acetyl-seryl-aspartyl-lysyl-proline on bile duct ligation induced liver fibrosis in rats.
Zhang L; Xu LM; Chen YW; Ni QW; Zhou M; Qu CY; Zhang Y
World J Gastroenterol; 2012 Oct; 18(37):5283-8. PubMed ID: 23066324
[TBL] [Abstract][Full Text] [Related]
30. Protective effect of gastrodin on bile duct ligation-induced hepatic fibrosis in rats.
Zhao S; Li N; Zhen Y; Ge M; Li Y; Yu B; He H; Shao RG
Food Chem Toxicol; 2015 Dec; 86():202-7. PubMed ID: 26498411
[TBL] [Abstract][Full Text] [Related]
31. Hepatotoxicity effect of short-term Bradykinin potentiating factor in cholestatic rats.
Fahmy SR; Mohamed AS; Hosney M; Issa HA; Hassanein SS; Soliman AM
Toxicol Lett; 2019 Feb; 301():73-78. PubMed ID: 30458228
[TBL] [Abstract][Full Text] [Related]
32. The anti-inflammatory effect of celecoxib does not prevent liver fibrosis in bile duct-ligated rats.
Yu J; Hui AY; Chu ES; Go MY; Cheung KF; Wu CW; Chan HL; Sung JJ
Liver Int; 2009 Jan; 29(1):25-36. PubMed ID: 18435714
[TBL] [Abstract][Full Text] [Related]
33. [Inhibitory effect of angiotensin blockade on hepatic fibrosis in common bile duct-ligated rats].
Park DH; Baik SK; Choi YH; Kim MY; Rhim DW; Kim JW; Kwon SO; Cho MY; Kim CH; Ahn SC
Korean J Hepatol; 2007 Mar; 13(1):61-9. PubMed ID: 17380076
[TBL] [Abstract][Full Text] [Related]
34. Inhibition of integrin alphavbeta6 on cholangiocytes blocks transforming growth factor-beta activation and retards biliary fibrosis progression.
Patsenker E; Popov Y; Stickel F; Jonczyk A; Goodman SL; Schuppan D
Gastroenterology; 2008 Aug; 135(2):660-70. PubMed ID: 18538673
[TBL] [Abstract][Full Text] [Related]
35. Curcumin attenuates hepatic fibrosis and insulin resistance induced by bile duct ligation in rats.
Eshaghian A; Khodarahmi A; Safari F; Binesh F; Moradi A
Br J Nutr; 2018 Aug; 120(4):393-403. PubMed ID: 29880071
[TBL] [Abstract][Full Text] [Related]
36. Alterations of mast cells and TGF-beta1 on the silymarin treatment for CCl(4)-induced hepatic fibrosis.
Jeong DH; Lee GP; Jeong WI; Do SH; Yang HJ; Yuan DW; Park HY; Kim KJ; Jeong KS
World J Gastroenterol; 2005 Feb; 11(8):1141-8. PubMed ID: 15754394
[TBL] [Abstract][Full Text] [Related]
37. Silymarin retards collagen accumulation in early and advanced biliary fibrosis secondary to complete bile duct obliteration in rats.
Boigk G; Stroedter L; Herbst H; Waldschmidt J; Riecken EO; Schuppan D
Hepatology; 1997 Sep; 26(3):643-9. PubMed ID: 9303494
[TBL] [Abstract][Full Text] [Related]
38. Antifibrotic effect of silymarin in rat secondary biliary fibrosis is mediated by downregulation of procollagen alpha1(I) and TIMP-1.
Jia JD; Bauer M; Cho JJ; Ruehl M; Milani S; Boigk G; Riecken EO; Schuppan D
J Hepatol; 2001 Sep; 35(3):392-8. PubMed ID: 11592601
[TBL] [Abstract][Full Text] [Related]
39. Tumor necrosis factor-α promotes cholestasis-induced liver fibrosis in the mouse through tissue inhibitor of metalloproteinase-1 production in hepatic stellate cells.
Osawa Y; Hoshi M; Yasuda I; Saibara T; Moriwaki H; Kozawa O
PLoS One; 2013; 8(6):e65251. PubMed ID: 23755201
[TBL] [Abstract][Full Text] [Related]
40. Coffee consumption prevents fibrosis in a rat model that mimics secondary biliary cirrhosis in humans.
Arauz J; Zarco N; Hernández-Aquino E; Galicia-Moreno M; Favari L; Segovia J; Muriel P
Nutr Res; 2017 Apr; 40():65-74. PubMed ID: 28473062
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
